Jubilant Pharmova Limited (JUBLPHARMA.BO)
INR 881.1
(-0.37%)
INR 881.1
(-0.37%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 27.07 Billion INR | 1.55% |
| 2022 | 26.65 Billion INR | 20.54% |
| 2021 | 22.11 Billion INR | -5.14% |
| 2020 | 23.31 Billion INR | -34.93% |
| 2019 | 35.83 Billion INR | -6.7% |
| 2018 | 38.4 Billion INR | 18.91% |
| 2017 | 32.29 Billion INR | -10.12% |
| 2016 | 35.93 Billion INR | -13.58% |
| 2015 | 41.58 Billion INR | -5.68% |
| 2014 | 44.08 Billion INR | 12.5% |
| 2013 | 39.18 Billion INR | 0.7% |
| 2012 | 38.91 Billion INR | 9.51% |
| 2011 | 35.53 Billion INR | 32.87% |
| 2010 | 26.74 Billion INR | 0.2% |
| 2009 | 26.69 Billion INR | -25.03% |
| 2008 | 35.6 Billion INR | 124.66% |
| 2007 | 15.84 Billion INR | 103.77% |
| 2006 | 7.77 Billion INR | 33.38% |
| 2005 | 5.83 Billion INR | 74.42% |
| 2004 | 3.34 Billion INR | -16.06% |
| 2003 | 3.98 Billion INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 17.48 Billion INR | 109.4% |
| 2024 Q1 | 9.56 Billion INR | -64.66% |
| 2023 Q3 | 9.74 Billion INR | -63.84% |
| 2023 Q1 | 10.14 Billion INR | -61.95% |
| 2023 Q4 | 27.07 Billion INR | 177.92% |
| 2023 Q2 | 26.94 Billion INR | 165.62% |
| 2023 FY | 27.07 Billion INR | 1.55% |
| 2022 Q2 | 26.51 Billion INR | 169.34% |
| 2022 Q4 | 26.65 Billion INR | 215.14% |
| 2022 FY | 26.65 Billion INR | 20.54% |
| 2022 Q1 | 9.84 Billion INR | -55.5% |
| 2022 Q3 | 8.45 Billion INR | -68.09% |
| 2021 Q1 | 6.71 Billion INR | -71.21% |
| 2021 Q2 | 20.94 Billion INR | 211.96% |
| 2021 Q3 | 8.62 Billion INR | -58.8% |
| 2021 Q4 | 22.11 Billion INR | 156.32% |
| 2021 FY | 22.11 Billion INR | -5.14% |
| 2020 Q1 | 14.18 Billion INR | -60.42% |
| 2020 FY | 23.31 Billion INR | -34.93% |
| 2020 Q3 | 11.72 Billion INR | -62.12% |
| 2020 Q4 | 23.31 Billion INR | 98.81% |
| 2020 Q2 | 30.96 Billion INR | 118.33% |
| 2019 Q2 | 33.3 Billion INR | 125.45% |
| 2019 FY | 35.83 Billion INR | -6.7% |
| 2019 Q1 | 14.77 Billion INR | -61.53% |
| 2019 Q3 | 14.51 Billion INR | -56.41% |
| 2019 Q4 | 35.83 Billion INR | 146.81% |
| 2018 FY | 38.4 Billion INR | 18.91% |
| 2018 Q4 | 38.4 Billion INR | 516.17% |
| 2018 Q3 | 6.23 Billion INR | -81.37% |
| 2018 Q2 | 33.45 Billion INR | 892.62% |
| 2018 Q1 | 3.37 Billion INR | -89.56% |
| 2017 FY | 32.29 Billion INR | -10.12% |
| 2017 Q2 | 32.68 Billion INR | 566.42% |
| 2017 Q3 | 4.11 Billion INR | -87.4% |
| 2017 Q4 | 32.29 Billion INR | 683.96% |
| 2017 Q1 | 4.9 Billion INR | -86.35% |
| 2016 FY | 35.93 Billion INR | -13.58% |
| 2016 Q2 | 33.9 Billion INR | 872.27% |
| 2016 Q1 | 3.48 Billion INR | -91.61% |
| 2016 Q4 | 35.93 Billion INR | 932.73% |
| 2016 Q3 | 3.47 Billion INR | -89.74% |
| 2015 Q3 | 3.73 Billion INR | -88.19% |
| 2015 FY | 41.58 Billion INR | -5.68% |
| 2015 Q4 | 41.58 Billion INR | 1013.14% |
| 2015 Q2 | 31.62 Billion INR | 688.76% |
| 2015 Q1 | 4 Billion INR | -90.9% |
| 2014 Q4 | 44.08 Billion INR | 970.62% |
| 2014 FY | 44.08 Billion INR | 12.5% |
| 2014 Q2 | 34.15 Billion INR | 612.34% |
| 2014 Q1 | 4.79 Billion INR | -87.76% |
| 2014 Q3 | 4.11 Billion INR | -87.95% |
| 2013 Q4 | 39.18 Billion INR | 2712.64% |
| 2013 FY | 39.18 Billion INR | 0.7% |
| 2013 Q3 | 1.39 Billion INR | -94.82% |
| 2013 Q1 | 3.6 Billion INR | -90.75% |
| 2013 Q2 | 26.87 Billion INR | 646.39% |
| 2012 Q4 | 38.91 Billion INR | 0.0% |
| 2012 FY | 38.91 Billion INR | 9.51% |
| 2011 FY | 35.53 Billion INR | 32.87% |
| 2011 Q4 | 35.53 Billion INR | 0.0% |
| 2010 FY | 26.74 Billion INR | 0.2% |
| 2009 FY | 26.69 Billion INR | -25.03% |
| 2008 FY | 35.6 Billion INR | 124.66% |
| 2007 FY | 15.84 Billion INR | 103.77% |
| 2006 FY | 7.77 Billion INR | 33.38% |
| 2005 FY | 5.83 Billion INR | 74.42% |
| 2004 FY | 3.34 Billion INR | -16.06% |
| 2003 FY | 3.98 Billion INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | -600.277% |
| Aurobindo Pharma Limited | 3.69 Billion INR | -633.003% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 1052.347% |
| Granules India Limited | 9.28 Billion INR | -191.511% |
| Indoco Remedies Limited | 6.47 Billion INR | -318.016% |
| Achyut Healthcare Limited | -3.74 Million INR | 722790.87% |
| Ajanta Pharma Limited | -954.9 Million INR | 2935.061% |
| Alkem Laboratories Limited | -1.6 Billion INR | 1782.118% |
| Alpa Laboratories Limited | 35.36 Million INR | -76454.591% |
| Brooks Laboratories Limited | 49.48 Million INR | -54607.487% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 640.096% |
| Bajaj HealthCare Limited | 3.29 Billion INR | -720.624% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 2438.325% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | -109.649% |
| Eris Lifesciences Limited | 13.8 Billion INR | -96.083% |
| FDC Limited | -57.75 Million INR | 46976.299% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 731.747% |
| Gufic Biosciences Limited | 3.19 Billion INR | -747.505% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 751.857% |
| Ipca Laboratories Limited | 11.41 Billion INR | -137.157% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 2047.724% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -1300.575% |
| Lasa Supergenerics Limited | 205.79 Million INR | -13054.583% |
| Laurus Labs Limited | 24.38 Billion INR | -11.021% |
| Lupin Limited | 17.19 Billion INR | -57.466% |
| Mankind Pharma Limited | -9.9 Billion INR | 373.234% |
| Medicamen Biotech Limited | 160.31 Million INR | -16786.649% |
| Medico Remedies Limited | 78.67 Million INR | -34309.039% |
| Megasoft Limited | 1.28 Billion INR | -2005.866% |
| NATCO Pharma Limited | -5.81 Billion INR | 565.395% |
| Piramal Pharma Limited | 42.27 Billion INR | 35.964% |
| RPG Life Sciences Limited | -364.7 Million INR | 7523.087% |
| Sigachi Industries Limited | 859.94 Million INR | -3048.094% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 137.356% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | -18573.436% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -58483.454% |
| Unichem Laboratories Limited | 931.91 Million INR | -2804.983% |
| Wanbury Limited | 1.1 Billion INR | -2348.016% |
| Windlas Biotech Limited | -273.04 Million INR | 10015.031% |
| ZIM Laboratories Limited | 983.6 Million INR | -2652.327% |
| Zydus Lifesciences Limited | 3.91 Billion INR | -592.025% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 2974.496% |
| Divi's Laboratories Limited | -39.77 Billion INR | 168.071% |
| Hester Biosciences Limited | 2.29 Billion INR | -1081.802% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 1252.981% |
| Amrutanjan Health Care Limited | -248.79 Million INR | 10981.379% |
| Bal Pharma Limited | 1.26 Billion INR | -2042.516% |
| Strides Pharma Science Limited | 23.25 Billion INR | -16.404% |
| Venus Remedies Limited | -267.7 Million INR | 10212.813% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | -936.487% |
| Nectar Lifesciences Limited | 6.15 Billion INR | -339.673% |
| Shilpa Medicare Limited | 9.06 Billion INR | -198.494% |
| Aarti Drugs Limited | 5.54 Billion INR | -387.924% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 2558.186% |
| Suven Life Sciences Limited | -1.63 Billion INR | 1758.114% |
| Ind-Swift Limited | 9.5 Billion INR | -184.711% |
| Valiant Laboratories Limited | -295.03 Million INR | 9275.954% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | -859.592% |
| Solara Active Pharma Sciences Limited | 10.02 Billion INR | -169.937% |
| Themis Medicare Limited | 764.96 Million INR | -3438.999% |
| Hikal Limited | 7.96 Billion INR | -239.802% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 14.948% |
| Sequent Scientific Limited | 4.17 Billion INR | -547.868% |
| Novartis India Limited | -5.89 Billion INR | 559.541% |
| Wockhardt Limited | 18.27 Billion INR | -48.177% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 146863.526% |
| Neuland Laboratories Limited | -214.05 Million INR | 12747.04% |
| Morepen Laboratories Limited | -231.17 Million INR | 11810.66% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | -22452.67% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | -2674.308% |